OKYO Pharma Ownership 2024 | Who Owns OKYO Pharma Now?

OverviewFinancials Chart

Institutional Ownership

0.13%

Insider Ownership

27.61%

Retail Ownership

72.26%

Institutional Holders

1.00

OKYO Pharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GOLDMAN SACHS GROUP INC	-	-	-	-19,807	-100.00%	-	Jun 30, 2023

OKYO Pharma's largest institutional shareholder is GOLDMAN SACHS GROUP INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GOLDMAN SACHS GROUP INC	-	-	-	-19,807	-100.00%	-	Jun 30, 2023

The largest OKYO Pharma shareholder by % of total assets is GOLDMAN SACHS GROUP INC. The company owns 0.00 shares of OKYO Pharma (OKYO), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GOLDMAN SACHS GROUP INC	-	-	-	-19,807	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, OKYO Pharma's largest institutional buyer is GOLDMAN SACHS GROUP INC. The company purchased -19.81K stocks of OKYO, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GOLDMAN SACHS GROUP INC	-	-	-	-19,807	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, OKYO Pharma's biggest institutional seller is GOLDMAN SACHS GROUP INC. The company sold -19.81K shares of OKYO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GOLDMAN SACHS GROUP INC	-	-	-	-19,807	-100.00%	-	Jun 30, 2023

OKYO Pharma's largest sold out institutional shareholder by shares sold is GOLDMAN SACHS GROUP INC, sold -19.81K shares, valued at -, as of undefined.

OKYO Pharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	12,090	-	-	Feb 29, 2024

OKYO Pharma's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 12.09K shares, compromising 0.00% of its total assets.

OKYO Pharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Sep, 22	1	-50.00%
30 Jun, 22	2	-

As of 31 Mar 23, 1 institutions are holding OKYO Pharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	19,807	163.29%
31 Dec, 22	7,523	536.46%
30 Sep, 22	1,182	-96.13%
30 Jun, 22	30,531	-

OKYO Pharma (OKYO) has 19.81K shares outstanding as of 31 Mar 23, up 163.29% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	0.13%	5276.35%
31 Dec, 22	0.05%	81597.44%
30 Sep, 22	0.01%	19.09%
30 Jun, 22	0.20%	-

As of 31 Mar 23, OKYO Pharma is held by 0.13% institutional shareholders, representing a 5276.35% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Sep, 22	-	-100.00%
30 Jun, 22	2	-

1 institutional shareholders have increased their position in OKYO stock as of 31 Mar 23 compared to 1 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-
31 Dec, 22	-	-100.00%
30 Sep, 22	1	-
30 Jun, 22	-	-

- institutional shareholders have reduced their position in OKYO stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	1	-	19,807	163.29%	0.13%	5276.35%	1	-	-	-
31 Dec, 22	1	-	7,523	536.46%	0.05%	81597.44%	1	-	-	-100.00%
30 Sep, 22	1	-50.00%	1,182	-96.13%	0.01%	19.09%	-	-100.00%	1	-
30 Jun, 22	2	-	30,531	-	0.20%	-	2	-	-	-

OKYO Pharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 28, 2023	BRANCACCIO JOHN P	director	-	P-Purchase	Buy	16,670	$1.50	$25.00K	16,670
May 20, 2022	CERRONE GABRIELE M	officer	Executive Chairman	P-Purchase	Buy	5,800,000	$0.08	$440.80K	548,981,215
May 19, 2022	JACOB GARY S	officer	Chief Executive Officer	P-Purchase	Buy	12,500	$4.00	$50.00K	12,500
May 19, 2022	CERRONE GABRIELE M	officer	Non-Executive Chairman	P-Purchase	Buy	37,500	$4.00	$150.00K	62,500
May 18, 2022	CERRONE GABRIELE M	director, 10 percent owner, officer	Non-Executive Chairman	P-Purchase	Buy	25,000	$3.87	$96.75K	25,000
May 18, 2022	CERRONE GABRIELE M	officer	Non-Executive Chairman	P-Purchase	Buy	1,625,000	$0.06	$96.69K	544,806,215

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 28, 2023	BRANCACCIO JOHN P	director	-	P-Purchase	Buy	16,670	$1.50	$25.00K	16,670
May 20, 2022	CERRONE GABRIELE M	officer	Executive Chairman	P-Purchase	Buy	5,800,000	$0.08	$440.80K	548,981,215
May 19, 2022	JACOB GARY S	officer	Chief Executive Officer	P-Purchase	Buy	12,500	$4.00	$50.00K	12,500
May 19, 2022	CERRONE GABRIELE M	officer	Non-Executive Chairman	P-Purchase	Buy	37,500	$4.00	$150.00K	62,500
May 18, 2022	CERRONE GABRIELE M	director, 10 percent owner, officer	Non-Executive Chairman	P-Purchase	Buy	25,000	$3.87	$96.75K	25,000
May 18, 2022	CERRONE GABRIELE M	officer	Non-Executive Chairman	P-Purchase	Buy	1,625,000	$0.06	$96.69K	544,806,215

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2022	Shah Keeren	officer	Chief Financial Officer	Sell	500,000	$0.06	$32.00K	-
May 16, 2022	Shah Keeren	officer	Chief Financial Officer	Sell	300,000	$0.20	$60.75K	-
May 16, 2022	Shah Keeren	officer	Chief Financial Officer	Sell	150,000	$0.10	$15.68K	-
May 16, 2022	Simon Willy Jules	director	-	Sell	2,000,000	$0.06	$117.60K	-
May 16, 2022	BRANCACCIO JOHN P	director	-	Sell	450,000	$0.20	$91.13K	-
May 16, 2022	BRANCACCIO JOHN P	director	-	Sell	900,000	$0.06	$57.60K	-
May 16, 2022	BRANCACCIO JOHN P	director	-	Sell	100,000	$0.10	$10.45K	-
May 16, 2022	JACOB GARY S	director, officer	Chief Executive Officer	Sell	40,000,000	$0.07	$2.61M	-
May 16, 2022	JACOB GARY S	director, officer	Chief Executive Officer	Sell	13,000,000	$0.06	$832.00K	-
May 16, 2022	Denoyer Bernard	director	-	Sell	1,000,000	$0.10	$104.50K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Oct 31, 2023	CERRONE GABRIELE M	director, officer	Executive Chairman	J-Other	Buy	70,071	$1.50	$105.11K	9,177,903
Oct 31, 2023	CERRONE GABRIELE M	director, officer	Executive Chairman	J-Other	Buy	499,468	$1.50	$749.20K	9,107,832
Sep 28, 2023	BRANCACCIO JOHN P	director	-	P-Purchase	Buy	16,670	$1.50	$25.00K	16,670
May 20, 2022	CERRONE GABRIELE M	officer	Executive Chairman	P-Purchase	Buy	5,800,000	$0.08	$440.80K	548,981,215
May 19, 2022	JACOB GARY S	officer	Chief Executive Officer	P-Purchase	Buy	12,500	$4.00	$50.00K	12,500
May 19, 2022	CERRONE GABRIELE M	officer	Non-Executive Chairman	P-Purchase	Buy	37,500	$4.00	$150.00K	62,500
May 18, 2022	CERRONE GABRIELE M	director, 10 percent owner, officer	Non-Executive Chairman	P-Purchase	Buy	25,000	$3.87	$96.75K	25,000
May 18, 2022	CERRONE GABRIELE M	officer	Non-Executive Chairman	P-Purchase	Buy	1,625,000	$0.06	$96.69K	544,806,215
May 16, 2022	Shah Keeren	officer	Chief Financial Officer		Sell	500,000	$0.06	$32.00K	-
May 16, 2022	Shah Keeren	officer	Chief Financial Officer		Sell	300,000	$0.20	$60.75K	-
May 16, 2022	Shah Keeren	officer	Chief Financial Officer		Sell	150,000	$0.10	$15.68K	-
May 16, 2022	Simon Willy Jules	director	-		Sell	2,000,000	$0.06	$117.60K	-
May 16, 2022	BRANCACCIO JOHN P	director	-		Sell	450,000	$0.20	$91.13K	-
May 16, 2022	BRANCACCIO JOHN P	director	-		Sell	900,000	$0.06	$57.60K	-
May 16, 2022	BRANCACCIO JOHN P	director	-		Sell	100,000	$0.10	$10.45K	-
May 16, 2022	JACOB GARY S	director, officer	Chief Executive Officer		Sell	40,000,000	$0.07	$2.61M	-
May 16, 2022	JACOB GARY S	director, officer	Chief Executive Officer		Sell	13,000,000	$0.06	$832.00K	-
May 16, 2022	CERRONE GABRIELE M	director, 10 percent owner, officer	Executive Chairman		Buy	-	-	-	543,181,215
May 16, 2022	Denoyer Bernard	director	-		Sell	1,000,000	$0.10	$104.50K	-

The last insider sell of OKYO Pharma's stock was made by Shah Keeren on May 16 2022, selling 500,000 shares at $0.06 per share (valued at $32.00K). The last insider buy of OKYO was made by BRANCACCIO JOHN P on Sep 28 2023, buying 16,670 shares at $1.50 per share (worth $25.00K).

OKYO Pharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2022	5	10	50.00%

5 total buy trades, and 10 total sell trades (buy/sell ratio of 0.50%) were made by OKYO Pharma's insiders, as of Q2 2022.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2022	5	-	-

As of Q2 2022, Insider owners conducted 5 open market buy trades and 0 open market sell trades of OKYO Pharma's stocks.

OKYO Pharma Peer Ownership

Ticker	Company
SNTI	Senti Biosciences, Inc.
MGTA	Dianthus Therapeutics, Inc.
FHTX	Foghorn Therapeutics Inc.
CVKD	Cadrenal Therapeutics, Inc. Common Stock
PXMD	PaxMedica, Inc. Common Stock
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
CMND	Clearmind Medicine Inc.
VRAX	Virax Biolabs Group Limited
CADL	Candel Therapeutics, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
UNCY	Unicycive Therapeutics, Inc.
CDIO	Cardio Diagnostics Holdings, Inc.

OKYO Ownership FAQ

Who Owns OKYO Pharma?

OKYO Pharma is owned by institutional shareholders (0.13%), insiders (27.61%), and public (72.26%). The largest institutional shareholder of OKYO Pharma is GOLDMAN SACHS GROUP INC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of OKYO Pharma?

OKYO Pharma's major institutional shareholders are GOLDMAN SACHS GROUP INC. The top five shareholders own together 0% of the company's share outstanding.

How many OKYO Pharma shareholders are there?

As of Mar 2023, there are 1 institutional shareholders of OKYO Pharma.

What percentage of OKYO Pharma is owned by GOLDMAN SACHS GROUP INC?

GOLDMAN SACHS GROUP INC owns 0 shares of OKYO Pharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).